Reversion of cardiac dysfunction by a novel orally...

Cardiovascular Research 2019 / 04

Reversion of cardiac dysfunction by a novel orally available calcium/calmodulin-dependent protein kinase II inhibitor, RA306, in a genetic model of dilated cardiomyopathy

Beauverger, Philippe, Ozoux, Marie-Laure, Bégis, Guillaume, Glénat, Valérie, Briand, Véronique, Philippo, Marie-Claire, Daveu, Cyril, Tavares, Georges, Roy, Sébastien, Corbier, Alain, Briand, Pascale,
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Journal:
Cardiovascular Research
DOI:
10.1093/cvr/cvz097
Date:
April, 2019
File:
PDF, 815 KB
2019
Conversion to is in progress
Conversion to is failed